No, Azopt is not classified as a beta-blocker. Beta-blockers belong to a category of medications used to address various conditions such as heart failure, high blood pressure, and elevated eye pressure in glaucoma treatment. They function by slowing down heart rate, which alleviates stress on the cardiovascular system, ultimately leading to reduced blood pressure and eye pressure.

Azopt, conversely, falls under the category of carbonic anhydrase inhibitors. Its primary mechanism of action involves diminishing intraocular pressure by decreasing the production of natural eye fluids. It is essential to note that while Azopt is not a beta-blocker, beta-blocker eye drops can be employed to manage elevated eye pressure.